Next Article in Journal
Properties of Naked Silver Clusters with Up to 100 Atoms as Found with Embedded-Atom and Density-Functional Calculations
Previous Article in Journal
Do Ganoderma Species Represent Novel Sources of Phenolic Based Antimicrobial Agents?
Previous Article in Special Issue
Synthesis of 6-Alkynylated Purine-Containing DNA via On-Column Sonogashira Coupling and Investigation of Their Base-Pairing Properties
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis and Behavior of DNA Oligomers Containing the Ambiguous Z-Nucleobase 5-Aminoimidazole-4-carboxamide

Graduate School of Pharmaceutical Science, Tokushima University, 1-78-1 Shomachi, Tokushima 770-8505, Japan
*
Authors to whom correspondence should be addressed.
Molecules 2023, 28(7), 3265; https://doi.org/10.3390/molecules28073265
Submission received: 9 March 2023 / Revised: 4 April 2023 / Accepted: 4 April 2023 / Published: 6 April 2023
(This article belongs to the Special Issue Organic Synthesis and Functional Evaluation of Nucleic Acids)

Abstract

:
5-Amino-1-β-D-ribofuranosylimidazole-4-carboxamide 5′-monophosphate (ZMP) is a central intermediate in de novo purine nucleotide biosynthesis. Its nucleobase moiety, 5-aminoimidazole-4-carboxamide (Z-base), is considered an ambiguous base that can pair with any canonical base owing to the rotatable nature of its 5-carboxamide group. This idea of ambiguous base pairing due to free rotation of the carboxamide has been applied to designing mutagenic antiviral nucleosides, such as ribavirin and T-705. However, the ambiguous base-pairing ability of Z-base has not been elucidated, because the synthesis of Z-base-containing oligomers is problematic. Herein, we propose a practical method for the synthesis of Z-base-containing DNA oligomers based on the ring-opening reaction of an N1-dinitrophenylhypoxanthine (HxaDNP) base. Thermal denaturation studies of the resulting oligomers revealed that the Z-base behaves physiologically as an A-like nucleobase, preferentially forming pairs with T. We tested the behavior of Z-base-containing DNA oligomers in enzyme-catalyzed reactions: in single nucleotide insertion, Klenow fragment DNA polymerase recognized Z-base as an A-like analog and incorporated dTTP as a complementary nucleotide to Z-base in the DNA template; in PCR amplification, Taq DNA polymerase similarly incorporated dTTP as a complementary nucleotide to Z-base. Our findings will contribute to the development of new mutagenic antiviral nucleoside analogs.

1. Introduction

5-Amino-1-β-D-ribofuranosylimidazole-4-carboxamide 5′-monophosphate (ZMP, also known as AICAR 5′-monophosphate) is a central intermediate in the de novo purine nucleotide biosynthesis, an ancient metabolic pathway common to most organisms. In the final step of purine nucleotide biosynthesis, ZMP is converted into 5-formylated ZMP, which in turn is converted into inosine 5′-monophosphate, a precursor of AMP and GMP.
The nucleobase of ZMP, 5-aminoimidazole-4-carboxamide (Z-base), is expected to pair with any canonical base, owing to the rotatable nature of its 5-carboxamide group (Figure 1a) [1,2]. This flexibility of the carboxamide group has been utilized in the design of mutagenic antiviral nucleosides [3,4]. For example, ribavirin (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) has a rotatable 3-carboxamide group on its triazole nucleobase (Figure 1b) [5,6,7], and in vitro studies have shown that the hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) can incorporate ribavirin 5′-triphosphate as a nucleotide analog of either ATP or GTP [8]. The ambiguous behavior of ribavirin causes G-to-A and C-to-U transition mutations in the viral genome and results in antiviral activity against a variety of RNA viruses [7,9,10,11]. Furthermore, when ribavirin itself is used as the template sequence, ribavirin-templated incorporation of CTP by HCV RdRp is four times more efficient than that of UTP, indicating that ribavirin, as an ambiguous purine analog, shows bias towards being more guanine (G)-like than adenine (A)-like.
Similarly, T-705 (6-fluoro-3-hydroxy-2-pyrazinecarboxamide, favipiravir), a broad-spectrum antiviral agent clinically used to treat influenza infection, is also an ambiguous base-pairing analog (Figure 1c) [12,13,14]. Due to free rotation of the 2-carboxamide group of T-705, the viral polymerase recognizes T-705 ribonucleoside 5′-triphosphate (T705-TP) as both a G-like and an A-like analog [15]. Detailed kinetic analysis of the single nucleotide insertion reaction has shown that T705-TP is more efficiently incorporated as a complement to C rather than U on the viral RNA template; which, means that the 2-carboxamide group of T-705 is preferentially present in a G-like configuration.
For Z-nucleotides, by contrast, there are few reports on whether the Z-base behaves as an ambiguous base, except for the study of Sabina et al., which shows that ZTP, as well as ATP, is a substrate for the reverse reaction catalyzed by 5-phosphoribosyl-1-pyrophosphate (PRPP) synthase [16].
Herein, therefore, we have explored a simple method to prepare DNA oligomers containing Z-bases based on the ring-opening reaction of an N1-dinitrophenylhypoxanthine (HxaDNP) base. By performing thermal and thermodynamic analysis of the resulting DNA duplexes containing a Z-base, we reveal that Z-base behaves as an A-like analog that forms a stable pair with T, rather than a G-like analog that forms a pair with C. Furthermore, we show that DNA polymerases catalyze Z-templated incorporation of TTP, but little or no CTP. Our results suggest that the ambiguous Z-base functions as an A-like analog in DNA duplexes.

2. Results and Discussions

2.1. Chemistry

To prepare DNA oligomers containing Z-bases, it is important to protect the Z-base. As we and others have previously reported, the sensitivity of the Z-base to ring closure into a purine, coupled with the possible dehydration of the 4-carboxamide group to form a cyano group, renders the choice of protecting group for the Z-base more difficult relative to standard nucleobases [1,17]. In previous studies, therefore, construction of Z-base by heat treatment of a N1-dinitrophenylhypoxanthine (HxaDNP) base with ethylenediamine has been applied to the synthesis of various Z-nucleoside or Z-nucleotide analogs [17,18,19,20,21]. In this study, to prepare DNA oligomers containing Z-base via this approach, the 5′-OH group of 2′-deoxyinosine (1) was first protected with 2,4-dimethoxytrityl chloride (DMTrCl) in pyridine with 75% yield (Scheme 1). The resulting product 2 was treated with 1-chloro-2,4-dinitrobenzene in DMF in the presence of K2CO3 to give 3 (85% yield). Lastly, 3 was converted to the phosphoramidite derivative 4 (66%) under standard conditions.
With the desired phosphoramidite unit 4 in hand, we next prepared different DNA oligomers containing Z-base. The schematic procedure is shown in Figure 2a. First, a 15-mer oligodeoxynucleotide (ODN) with a HxaDNP-base in the middle of the sequence (ODN1) was prepared by using an automatic DNA/RNA synthesizer. It was then treated with ethylenediamine at 50 °C for 30 min, and an aliquot of the reaction mixture was analyzed by using LC-MS. The spectrum showed a major peak corresponding to the desired ODN2 possessing a Z-base (RT = 7.9 min, calcd for C145H186N54O88P14 4526.9700, observed 4526.9759), implying that (i) ring-opening of the HxaDNP-base to form Z-base, (ii) nucleobase deprotection of canonical bases [N6-benzoyl (Bz) group for adenine, N2-isobutyryl group for guanine, and N4-acetyl group for cytosine], and (iii) cleavage from the resin had successfully proceeded in one step (Figure 2b) [22]. However, a minor impurity peak (RT = 7.6 min) was also observed and determined to be ODN3 containing an N1-alkylated Hxa base. We also examined the potential incorporation of multiple Z-bases in ODN4; however, the undesired formation of N1-alkylated Hxa bases resulted in complex mixtures (Supplementary Materials: Figure S1a).
Our results allowed us to propose the following reaction mechanism (Figure S2). When the HxaDNP-base S1 is treated with ethylenediamine at 50 °C, the nucleophilic attack of the ethylenediamine on C2 of hypoxanthin ring occurs to form formamidine intermediate S2, which then undergoes the attack of a second diamine on the dinitrophenyl ipso carbon to yield the S3. Subsequent intramolecular attack on the formamidine carbon by the free terminal amino group of S3 leads to formation of the cyclic orthoamide S4 (path A). Then, a third diamine attacks the cyclic orthoamide carbon to yield the desired Z-base S5. However, if the N atom linked to the amidine carbon in S3 participates in reclosure of the purine by attacking the carbonyl group, the undesired N1-alkylated Hxa derivative S6 will form (path B).
To prove our hypothesis, we used density functional theory (DFT) to calculate thermodynamic parameters for the model substrate S1 with the sugar moiety replaced with a methyl substituent. We started by investigating the reaction profile from the intermediate S2, which is obtained via the ring opening reaction of S1 with ethelenediamine (n = 2). The calculations showed that, formation of the five-membered cyclic orthoamide (S3S4 via TSS3-S4, 40.9 kcal/mol) is the rate-limiting step to give the desired S5 (path A). In addition, the by-product S6 can form via path B (TSS3–S6, 38.7 kcal/mol). However, when the activation energies were calculated for the path A and path B taking the larger diamine (n = 3), the outcome was opposite (path A 38.2 kcal/mol versus path B 41.4 kcal/mol). This result of DFT calculations for our proposed mechanism suggested that the construction of a six-membered cyclic orthoamide with a longer C-chain diamine would proceed more easily than a five-membered one. Thus, we explored the Z-base construction with 1,3-propanediamine (n = 3), which would form a six-membered cyclic orthoamide intermediate.
Figure 2c shows the result of the treatment of support-bonded ODN1 with 1,3-propanediamine at 50 °C. Under these conditions, formation of the undesired N1-alkylated Hxa product was markedly reduced and the isolated yield of the desired ODN2 containing Z-base after HPLC purification was 35%; which, is similar to that in normal ODN synthesis. Moreover, this synthesis of ODN4 containing multiple Z-bases gave the desired sequence as the main product (Figure S1b).

2.2. Physical Assessment of the Base-Pairing Ability of Z-Base

Next, we investigated the base-pairing ability of Z-base by evaluating the melting temperature (Tm) of duplexes by ultraviolet (UV) absorbance. The Tm of 15-mer duplexes containing Z-base was measured in a buffer comprising 100 mM NaCl, 10 mM Na2HPO4, and 1 mM Na2EDTA (pH 7.0) (Figure 3). When a Z:T pair was formed at a position sandwiched between A:T pairs in the DNA duplex, the Tm value was 53.9 °C (entry 1, Figure 3). By contrast, the Tm value of a Z:C pair was much lower (entry 2, 43.8 °C) and almost equal to that of the natural mismatched A:C and A:A base pairs (entries 7 and 8, 47.7 °C and 49.4 °C, respectively). These results indicate that Z-base behaves as an A-like analog, forming a stable base pair with T in the DNA duplex, rather than as a G-like analog, which pairs with C. Furthermore, the possible formation of Z:G pairs (Tm = 52.4 °C, entry 4) strongly supports the idea that Z-base functions as an A-like analog, because it suggests the formation of a Hoogsteen-type base pair similar to A:G pairs (Tm = 51.6 °C, entry 9) (Figure S3). The calculated thermodynamic parameters (ΔH°, ΔS°, and ΔG°) also support these considerations. Given the influence of adjacent base pairs, we also evaluated the Tm values of duplexes in which the Z-base was sandwiched between G:C pairs (entries 10–13); which, showed that Z-base displayed similar base-paring behavior as when it was sandwiched between A:T pairs (entries 1–4).
The duplex containing a Z:T pair was less stable than the fully complementary A:T and C:G duplexes (entry 1 versus entries 5 and 6, Figure 3). We considered that this destabilization is due to loss of the stacking affinities of the nucleobase, which has been altered to an imidazole ring (Z-base) from a purine ring (A- and G-bases). Next, therefore, we prepared ODN6 with either a Z-base or a natural nucleobase at the position of the dangling end and evaluated the Tm values and thermodynamic parameters of the homoduplexes according to the method of Kool et al. [23] (Figure 4). The results showed that the ΔΔG° stacking affinity of a Z-base (imidazole) (entry 3) was less favorable than that of an A-base (purine) (entry 2) (–2.4 kcal mol–1 versus –1.2 kcal mol–1). Therefore, a decrease in the stacking affinity is likely to be one of the main reasons for the reduced thermal and thermodynamic stability of a Z:T pair relative to a natural A:T pair.

2.3. Enzymatic Assessment of the Base-Pairing Ability of Z-Base

Next, we assessed the behavior of the Z-base in enzyme-mediated processes by first examining single-nucleotide insertion by Klenow fragment DNA polymerases. The experiments were carried out with a template strand containing Z-base at position 21 from the 3′-end (represented as X, 30-mer, ODN 7), and a 5′-fluoresceinisothiocyanate (FITC)-labeled primer (20-mer) (Figure 5a) in the presence of each 2′-deoxynucleoside 5′-triphosphate (dNTP). As shown in Figure 5b, with the 3′→5′ exonuclease-deficient Klenow fragment (KF exo), only dTTP was incorporated as a complementary base against the Z-base in the template, giving a 21-mer sequence (lane 8) just as when the natural A-base was included in the template (lane 4); whereas, no other dNTPs were incorporated (lanes 6, 7 and 9). Moreover, the Klenow fragment with 3′→5′ exonuclease activity (KF exo+) also formed Z:T as a complementary base pair (lane 17), indicating that the Z:T pair was recognized as a natural Watson–Crick-like matched base pair.
To quantify the selectivity and efficiency of the single-nucleotide insertion experiments, we determined kinetic parameters, including the Michaelis constant (Km), maximum rate of enzyme reaction (Vmax), and incorporation efficiency (Vmax/Km), for the reaction by using each dNTP at various concentrations (Figure 5c). We found that the efficiency of dTTP incorporation was almost 19 times lower against Z-base in the template than against A in the template (Z:T pair, Vmax/Km = 1.37 × 107; A:T pair, 2.62 × 108). Nevertheless, the parameters strongly suggested that the ambiguous Z-base functions as an A-like analog during replication by DNA polymerase, forming a pair with T.
We also explored PCR amplification catalyzed Taq DNA polymerase with a DNA template containing Z-base. The experiment was carried out with an 87-mer template containing Z-base and two primers to give 104-bp amplicons (Figure 5d), and the resulting amplicons were sequenced to evaluate accumulated mutagenesis that occurred at the position of Z-base. As shown in Figure 5e, the PCR for the template with Z-base in the middle of the sequence proceeded with efficiency comparable to that of the natural template, yielding nearly equal amounts of amplicons. In addition, sequencing of the amplified product verified that dTTP was incorporated against Z-base in the template as a complementary nucleotide (Figure 5f). As described in the Introduction, the rotatable carboxamide group on ribavirin and T-705 prefers the G-like configuration rather than the A-like configuration. In contrast to ribavirin and T-705, our current results indicate that Z-base acts as an A-like analog. We consider that this different behavior might be influenced by the group neighboring the carboxamide in each nucleobase. Thus, in the case of ribavirin, a hydrogen bonding interaction between the N2 atom and the 3-carboxamide hydrogen atom would give preference to the G-like configuration (Figure 6a). Similarly, a potential interaction between the O3 atom and the 2-carboxamide hydrogen atom of T-705 would stabilize the G-like configuration (Figure 6b). By contrast, the 4-carboxamide group of Z-base prefers the A-like configuration due to a stabilizing interaction between the 5-amino hydrogen and the 4-carboxamide group (the G-like configuration would cause steric repulsion, Figure 6c). We believe that our results will contribute to the molecular design of new mutagenic antiviral nucleoside analogs.

3. Conclusions

In this study, we have succeeded in establishing a practical synthesis of DNA oligomers containing Z-base. Based on our precise MS analysis and DFT calculation-based considerations, we found that 1,3-propanediamine treatment was more effective than ethylenediamine treatment for the construction of Z-base via the ring-opening reaction of HxaDNP-base under heating conditions. Thermal and thermodynamic denaturing studies of the resulting DNA oligomers revealed that Z-bases preferentially form Z:T pairs like natural A:T pairs with the possible formation of a Hoogsteen-type Z:G pair similar to an A:G pair. Collectively, our results indicate that Z-base prefers an A-like configuration in the DNA duplex. To understand how Z-base behaves in enzyme-catalyzed processes, we measured the products of single nucleotide insertion by Klenow fragment DNA polymerase with a DNA template containing a Z-base in its sequence. With or without proofreading 3′→5′ exonuclease activity, Klenow fragment DNA polymerase selectively incorporated dTTP as a nucleotide complementary to the Z-base in the template, forming Z:T base pairs. PCR amplification of a template containing a Z-base also showed convergence to A:T pairs.
The behavior of Z-base as an A-like analog, as revealed by our results, distinguishes it from other mutagenic nucleosides with a carboxamide group on the nucleobase such as ribavirin and T-705, which both prefer a G-like configuration. We believe that this finding will contribute to the development of new mutagenic antiviral nucleoside analogs. Further evaluation of Z-base in transcription is currently underway.

4. Materials and Methods

4.1. General Methods

Analytical TLC was performed on Kieselgel F254 plates (Merck, Darmstadt, Germany) and visualized by UV light (254 nm, Axel, Osaka, Japan). Column chromatography was performed using Chemical silica gel 60N (neutral, KANTO Chemical, Tokyo, Japan). Physical data were obtained as follows. NMR spectra were recorded on a Bruker FT-NMR AV400 or AV500 instrument (Billerica, MA, USA). 1H NMR spectra were recorded at 400 or 500 MHz, referenced to TMS in CDCl3 (0.00 ppm), DMSO-d6 (2.50 ppm). 13C NMR spectra were recorded at 100 or 125 MHz, referenced to TMS in CDCl3 (0.00 ppm). 31P NMR spectrum was recorded at 162 or 202 MHz, referenced to phosphoric acid as an external reference in CDCl3 (0.00 ppm). Chemical shifts are reported in parts per million (δ), and signals are expressed as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), or br (broad). All exchangeable protons were detected by addition of D2O. Mass spectra were recorded on a quadrupole SQD2 spectrometer (Waters, Milford, MA, USA) for LRMS or a TOF SYNAPT G2-Si HDMS spectrometer (Waters) for HRMS. All the chemical reagents and solvents used were commercially available and used without further purification.

4.2. Chemistry

5′-O-(4,4′-Dimethoxytrityl)-2′-deoxyinosine (2). Under an argon atmosphere, to a solution of 1 (2.72 g, 10.8 mmol) in pyridine (100 mL) was added DMTrCl (4.39 g, 13.0 mmol) at 0 °C, and the whole was stirred for 7 h at room temperature. The reaction was quenched by addition of ice and concentrated in vacuo. Next, AcOEt was added to the residue and the resulting white precipitate was collected by filtration, and then washed with H2O followed by AcOEt to give 2 (4.26 g, 71%) as a white powder. LRMS (ESI) m/z: [M + Na]+ 577; HRMS (ESI) m/z: [M + H]+ calcd for C31H31N4O6 555.2238; found 555.2282; 1H NMR (DMSO-d6, 400 MHz) δ 12.38 (1 H, d, J = 3.9 Hz, exchangeable with D2O, -NH), 8.19 (1 H, s, H-8), 7.99 (1 H, d, J = 3.9 Hz, H-2), 7.33–7.31 (2 H, m, DMTr), 7.25–7.18 (7 H, m, DMTr), 6.83–6.78 (4 H, m, DMTr), 6.34 (1 H, dd, J = 6.3, 6.3 Hz, H-1′), 5.38 (1 H, s, exchangeable with D2O, -OH), 4.44–4.40 (1 H, m, H-3′), 3.99–3.95 (1 H, m, H-4′), 3.72 (each 3 H, each s, OMe), 3.17 (1 H, dd, J = 6.3, 10.2 Hz, H-5′a), 3.12 (1 H, dd, J = 3.9, 10.2 Hz, H-5′b), 2.77 (1 H, ddd, J = 6.3, 6.3, 12.9 Hz, H-2′a), 2.34 (1 H, ddd, J = 4.8, 6.3, 12.9 Hz, H-2′b); 13C{1H} NMR (DMSO-d6, 100 MHz) δ 158.0, 158.0, 156.6, 147.9, 145.6, 144.9, 138.7, 135.6, 135.5, 129.7, 129.6, 127.7, 127.7, 126.6, 124.6, 113.1, 113.1, 85.9, 85.4, 83.5, 70.5, 64.1, 55.0, 55.0.
N1-(2,4-Dinitrophenyl)-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyinosine (3). Under an argon atmosphere, to a solution of 2 (1.66 g, 3.0 mmol) in DMF (30 mL) containing K2CO3 (829 mg, 6.0 mmol) was added 1-chloro-2,4-dinitrobenzene (1.22 g, 6.0 mmol), and the mixture was heated for 1 h at 80 °C in an oil bath. After being cooled to room temperature, the reaction mixture was filtered through a celite pad and the residue was washed with AcOEt. The solvent was removed in vacuo and the residue was dissolved in AcOEt. The organic layer was washed with H2O (three times) followed by brine. The separated organic layer was dried (Na2SO4) and concentrated in vacuo. The residue was purified by a silica gel column, eluted with MeOH in CHCl3 (0–6%), to give 3 (1.85 g, 85%) as a yellow foam. LRMS (ESI) m/z: [M + Na]+ 743; HRMS (ESI) m/z: [M + H]+ calcd for C37H33N6O10 721.2253; found 721.2254; 1H NMR (CDCl3, 400 MHz) δ 9.03 (each 0.5 H, each d, J = 2.8 Hz, DNP), 8.65 (0.5 H, dd, J = 2.4, 2.4 Hz, DNP), 8.62 (0.5 H, dd, J = 2.4, 2.4 Hz, DNP), 7.98 (0.5 H, s, H-8), 7.96 (0.5 H, s, H-8), 7.93 (0.5 H, s, H-2), 7.85 (0.5 H, s, H-2), 7.66 (0.5 H, d, J = 8.6 Hz, DNP), 7.61 (0.5 H, d, J = 8.6 Hz, DNP), 7.41–7.39 (2 H, m, DMTr), 7.31–7.19 (7 H, m, DMTr), 6.83–6.79 (4 H, m, DMTr), 6.44 (0.5 H, dd, J = 6.5, 6.5 Hz, H-1′), 6.40 (0.5 H, dd, J = 6.5, 6.5 Hz, H-1′), 4.72–4.66 (1 H, m, H-3′), 4.18–4.15 (1 H, m, H-4′), 3.77 (each 1.5 H, each s, OMe), 3.77 (3 H, 2 s, OMe), 3.47, 3.44 (1 H, each dd, J = 4.6, 10.2 Hz, J = 4.4, 10.2 Hz, H-5′a), 3.37, 3.36 (1 H, each dd, J = 3.8, 10.6 Hz, J = 3.9, 10.2 Hz, H-5′b), 2.84 (0.5H, ddd, J = 6.5, 6.5, 13.3 Hz, H-2′a), 2.72 (0.5 H, ddd, J = 6.5, 6.5, 13.3 Hz, H-2′b), 2.60 (0.5 H, ddd, J = 4.5, 6.5, 14.1 Hz, H-2′a), 2.57 (0.5 H, each ddd, J = 4.5, 6.5, 13.3 Hz, H-2′b), 2.28 (0.5 H, d, J = 3.5 Hz, exchangeable with D2O, -OH), 2.23 (0.5 H, d, J = 3.5 Hz, exchangeable with D2O, -OH); 13C{1H} NMR (CDCl3, 125 MHz) δ 158.6, 158.6, 158.6, 155.2, 148.1, 147.3, 147.2, 146.3, 146.3, 144.9, 144.7, 144.5, 144.5, 139.5, 138.9, 135.7, 135.6, 135.6, 135.6, 135.5, 131.9, 131.8, 130.1, 130.1, 130.0, 128.8, 128.8, 128.1, 128.1, 128.0, 127.9, 127.0, 127.0, 124.4, 124.1, 121.3, 121.3, 113.3, 113.2, 86.7, 86.6, 86.4, 86.3, 84.8, 84.3, 72.4, 72.3, 63.8, 63.7, 55.3, 40.9, 40.4.
N1-(2,4-Dinitrophenyl)-3′-O-{2-cyanoethoxy-(N,N-diisopropylamino)phosphino}-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyinosine (4). Under an argon atmosphere, a solution of 3 (360 mg, 0.5 mmol) in CH2Cl2 (10 mL) containing 4Å MS (200 mg) was stirred for 1 h at room temperature. Then, 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (167 mL, 0.75 mmol), N,N-diisopropylethylamine (DIPEA) (348 mL, 2.0 mmol), and 4-dimethylaminopyridine (DMAP) (3 mg 0.025 mmol) were added to the above solution at 0 °C, and the whole was stirred for 80 min at room temperature. The reaction mixture was diluted with CHCl3, washed with H2O (twice), and saturated NaHCO3 followed by brine, dried over Na2SO4, and concentrated in vacuo. The residue was purified by a silica gel column, eluted with hexane/AcOEt (1/2–1/3), to give 4 (304 mg, 66%) as a pale brown foam. LRMS (ESI) m/z: [M + Na]+ 943; HRMS (ESI) m/z: [M + H]+ calcd for C46H50N8O11P 921.3331; found 921.3375; 1H NMR (CDCl3, 500 MHz) δ 9.05 (0.5 H, d, J = 2.5 Hz, DNP), 9.04 (0.5 H, d, J = 2.5, DNP), 8.67–8.63 (1 H, m, DNP), 8.04 (0.2 H, s, H-8), 8.01 (0.5 H, s, H-8), 8.00 (0.3 H, s, H-8), 7.95 (0.2 H, s, H-2), 7.94 (0.3 H, s, H-2), 7.86 (0.3 H, s, H-2), 7.85 (0.2 H, s, H-2), 7.70 and 7.69 (total 0.5 H, each d, J = 8.6 Hz, J = 8.6 Hz, DNP), 7.61 (0.3 H, d, J = 8.6 Hz, DNP), 7.59 (0.2 H, d, J = 8.6 Hz, DNP), 7.42–7.41 (2 H, m, DMTr), 7.32–7.19 (7 H, m, DMTr), 6.83–6.78 (4 H, m, DMTr), 6.46–6.43 (0.5 H, m, H-1′), 6.41–6.38 (0.5 H, m, H-1′), 4.85–4.74 (1 H, m, H-3′), 4.36–4.34 (0.5 H, m, H-4′), 4.33–4.30 (0.5 H, m, H-4′), 3.91–3.83 (1 H, m, CH2), 3.78, 3.78, 3.77, 3.77, 3.77 (6 H, 5 s, OMe), 3.76–3.56 (3 H, m, CH2), 3.43–3.33 (2 H, m, H-5′a, H-5′b), 2.97–2.88 (0.5H, m, H-2′a), 2.83–2.60 (2.5 H, m, H-2′a, H-2′b, CH), 2.49–2.46 (1 H, m, CH), 1.21, 1.21, 1.20, 1.20, 1.19, 1.19, 1.18, 1.14, 1.12 (total 12 H, each s, CH3); 13C{1H} NMR (CDCl3, 125 MHz) δ 158.6, 158.6, 158.5, 158.5, 158.5, 155.2, 155.2, 148.1, 148.1, 147.4, 147.3, 147.2, 147.2, 146.4, 144.8, 144.6, 144.6, 144.5, 144.5, 144.4, 139.7, 139.5, 138.9, 138.8, 135.8, 135.7, 135.7, 135.6, 135.6, 135.6, 135.4, 135.4, 131.9, 130.2, 130.1, 130.1, 130.0, 128.8, 128.7, 128.2, 128.1, 128.1, 128.1, 127.9, 127.9, 127.0, 127.0, 126.9, 124.7, 124.6, 124.4, 124.3, 121.3, 117.6, 117.6, 117.5, 117.4, 113.2, 113.1, 113.1, 86.6, 86.6, 86.5, 86.5, 86.3, 86.2, 86.2, 86.0, 86.0, 85.9, 85.1, 85.1, 84.5, 84.5, 74.1, 73.9, 73.6, 73.5, 73.5, 73.4, 63.5, 63.4, 63.3, 63.2, 58.4, 58.3, 58.3, 58.2, 58.2, 58.1, 58.1, 57.9, 55.3, 55.2, 43.3, 43.3, 43.2, 43.2, 40.3, 40.3, 40.2, 40.2, 40.2, 39.9, 39.7, 39.7, 24.7, 24.6, 24.6, 24.6, 24.5, 21.5, 20.5, 20.4, 20.3, 20.2; 31P NMR (CDCl3, 202 MHz) δ 149.47, 149.37, 149.24.

4.3. Oligonucleotide Synthesis

CPG-supported ODNs were prepared on an H-6 DNA/RNA synthesizer (Nihon Techno Service, Ibaragi, Japan) using the corresponding phosphoramidite units (Glen research, Sterling, VA, USA) and CPG (Glen research) resin at a 0.4 μmol scale, according to the following procedure: detritylation (3% TCA in CH2Cl2, 70 s), coupling [0.25 M 5-benzyl-1H-tetrazole in dry acetonitrile, 12 min for 4 in 0.1 M dry acetonitrile, 30 s for natural nucleoside phosphoramidites in 0.065 M dry acetonitrile], capping [Ac2O in THF/pyridine and 1-methylimidazole in THF, 60 s], and oxidation [0.02 M I2 in THF/H2O/pyridine, 180 s]. After completion of synthesis, the CPG support was treated with ethylenediamine and/or 1,3-propanediamine for 30 min at 50 °C. The reaction was concentrated in vacuo, and the residue containing DMTr-ON products was combined with 0.2 M TEAA buffer (1.0 mL) and applied to a C18 cartridge column (YMC Dispo SPE C18, YMC, Kyoto, Japan). The cartridge was washed with 10% acetonitrile in 0.2 M TEAA (pH 7.0) to rinse failed sequences from the cartridge, and then with 2% trifluoroacetic acid to remove the DMTr group at the 5′-end. ODNs were eluted with 20–50% acetonitrile and evaporated to dryness before characterization by ESI-TOF mass analysis (see Table S1).

4.4. Calculation Details

Density functional theory (DFT) calculations on the model substrate were performed with the Gaussian09 suite of programs (Revision B.01, Gaussian, Inc., 340 Quinnipiac St., Bldg. 40, Wallingford CT 06492, USA) [24]. Geometries of all molecules and transition states were fully optimized without any symmetry constrains using the B3LYP method combined with the 6-31G*(d,p) basis set. Vibrational analyses were performed at the same level of theory on all optimized geometries to ensure that the optimized structures corresponded to local minima. All transition states were confirmed by one imaginary frequency. All energies reported in this paper and used for discussion refer to the sum of electronic and zero-point energies in Hartrees and relative energies in kcal/mol.

4.5. Thermal and Thermodynamic Analysis

Ultraviolet (UV) absorbance was measured on a UV-1800 spectrophotometer equipped with a temperature controller (SHIMAZU, Kyoto, Japan). Melting curves of DNA duplexes were acquired at 260 nm (Tm analysis, Figure 3) or 280 nm (stacking analysis, Figure 4) in 100 mM (Tm analysis, Figure 3) or 1.0 M (stacking analysis, Figure 4) NaCl, 10 mM Na2HPO4, and 1 mM Na2EDTA (pH 7.0). Samples were heated from 20 to 95 °C at a rate of 0.5 °C min–1. Before the measurements, the DNA duplexes were heated to 95 °C and then cooled to 20 °C. All melting curves were fitted to a theoretical equation to obtain thermodynamic parameters for double helix formation (∆H°, ∆S°, and ∆G°37) as described elsewhere [25]. We also evaluated these thermodynamic parameters from plots of the reciprocal of melting temperature (Tm−1) versus ln(Ct/4). From the slope and intercept of the plots, thermodynamic parameters were obtained as described elsewhere [24]. We measured melting curves for at least 10 different concentrations of DNA duplex (1.0 μM to 40 μM for Tm analysis, Figure 3; 1.5 μM to 100 μM for stacking analysis, Figure 4). The thermodynamic parameters listed in Figure 3 and Figure 4 are the average values obtained from curve fitting, and plots of Tm−1 versus ln (Ct/4).

4.6. Single Nucleotide Insertion Analysis

A primer labeled with FITC at the 5′-end (20-mer, 5′-FITC-GTTCTGGATGGTCAGCGCAC-3′) was annealed with a template (30-mer, ODN6; see Table S1) in 10 mM Tris-HCl (pH 7.9) buffer containing 50 mM NaCl, 10 mM MgCl2, and 1 mM DTT. The primer–template duplex solution (final 0.2 or 0.8 μM) was mixed with each dNTP solution (final 0.05–5 μM). Each mixture was incubated for more than 2 min, and then the reaction was initiated by adding enzyme (final 0.025 units μL−1) to each duplex–dYTP mixture at 37  °C. Reactions were quenched with an equal amount of stop solution (0.1 % (w/v) bromophenol blue (BPB), 10  M urea, and 50 mM ethylenediaminetetraacetic acid (EDTA)). The diluted products were resolved by electrophoresis on a 20% polyacrylamide gel containing 8 M urea, and the gels were visualized with a Typhoon FLA 9500 scanner (Cytiva, Tokyo, Japan) equipped with ImageQuantTM software (cytiva). Relative velocities (v0) were calculated as the extent of the reaction divided by the reaction time and were normalized to the duplex and enzyme concentration (0.2 μM, 0.025 units μL−1) for the various concentrations used. The kinetic parameters (Km and Vmax) were obtained from Lineweaver–Burk plots of 1/v0 versus 1/[dNTP].

4.7. PCR and Sequencing Analysis

PCR was performed using Taq DNA Polymerase (New England Biolabs, Ipswich, MA, USA) with dNTPs. The reaction mixture contained 0.5 pM template, 1×ThermoPol® Buffer (New England Biolabs), 0.5 μM primers (Forward, 5′-TAATACGACTCACTATAGGGACTAGCTACGAGTGCTC-3′; Reversed, 5′-GACGGAATATAAGCTGGTGG-3′), 0.2 mM dNTPs, and 0.025 units μL−1 of Taq DNA polymerase in a volume of 50 μL. The cycling conditions were 30 cycles of denaturation at 95 °C for 30 s, annealing at 55 °C for 30 s, and extension at 68 °C for 30 s. The reactions were analyzed by 6.4% polyacrylamide gel electrophoresis and stained with ethidium bromide. The amplicons were purified using a High Pure PCR Product Purification Kit (Roche Diagonostics, Tokyo, Japan), and the resulting products (1.125 μg) were each sequenced with 4 pmol of primer (5′-TAATACGACTCACTATAGGGACTAGCTACGAGTGCTC-3′) using an ABI PRISM 3100 Genetic Analyzer (Waltham, MA, USA).

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28073265/s1, Figure S1: Synthesis of the ODN4 containing multiple Z-bases; Figure S2: Proposed mechanism of Z-base construction by ring-opening reaction of an HxaDNP-base (DFT calculation result with the calculated activation barriers); Figure S3: Possible formation of a Hoogsteen-type Z:G pair similar to a natural A:G pair; Table S1: Characterization of ODNs containing Z-bases; NMR spectra of compounds 2–4; Cartesian coordinates of intermediates and transition states.

Author Contributions

Conceptualization, N.S.-T.; chemical synthesis and physical/enzymatic assessment Y.N.; calculation analysis, S.K.; data curation, Y.N. and N.S.-T.; writing—original draft preparation, N.S.-T. and S.K.; writing—review and editing, N.S.-T. and N.M.; supervision, N.S.-T. and N.M.; funding acquisition, N.S.-T. and N.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data from this study are reported in the text or in “Supplementary Materials”.

Acknowledgments

We thank Kosuke Namba for kindly providing the workstation for calculation. This work was financially supported in part by JSPS KAKENHI Grant Numbers 22K06527 (N.S.T.), the Naito Foundation (N.S.T.). Y.N. is grateful to the research program for development of intelligent Tokushima artificial exosome (iTEX) from Tokushima University.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Compounds 24 and ODNs 27 are available from the authors.

References

  1. Pochet, S.; Dugué, L. Oligodeoxynucleotides Embodying the Ambiguous Base Z, 5-Amino-Imidazole-4-Carboxamide. Nucleosides Nucleotides 1995, 14, 1195–1210. [Google Scholar] [CrossRef]
  2. Sala, M.; Pezo, V.; Pochet, S.; Wain-Hobson, S. Ambiguous Base Pairing of the Purine Analogue 1-(2-Deoxy-Beta-D-Ribofuranosyl)-Imidazole-4-Carboxamide during PCR. Nucleic Acids Res. 1996, 24, 3302–3306. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Bonnac, L.F.; Mansky, L.M.; Patterson, S.E. Structure-Activity Relationships and Design of Viral Mutagens and Application to Lethal Mutagenesis. J. Med. Chem. 2013, 56, 9403–9414. [Google Scholar] [CrossRef]
  4. Hadj Hassine, I.; Ben M’hadheb, M.; Menéndez-Arias, L. Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity. Viruses 2022, 14, 841. [Google Scholar] [CrossRef] [PubMed]
  5. Sidwell, R.W.; Huffman, J.H.; Khare, G.P.; Allen, L.B.; Witkowski, J.T.; Robins, R.K. Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide. Science 1972, 177, 705–706. [Google Scholar] [CrossRef]
  6. Smith, R.A.; Kirkpatrick, W. Ribavirin: A Broad Spectrum Antiviral Agent. In Ribavirin: A Broad Spectrum Antiviral Agent; Academic Press, Inc.: New York, NY, USA, 1980; ISBN 9780126523508. [Google Scholar]
  7. Crotty, S.; Maag, D.; Arnold, J.J.; Zhong, W.; Lau, J.Y.; Hong, Z.; Andino, R.; Cameron, C.E. The Broad-Spectrum Antiviral Ribonucleoside Ribavirin Is an RNA Virus Mutagen. Nat. Med. 2000, 6, 1375–1379. [Google Scholar] [CrossRef] [PubMed]
  8. Vo, N.V.; Young, K.-C.; Lai, M.M.C. Mutagenic and Inhibitory Effects of Ribavirin on Hepatitis C Virus RNA Polymerase. Biochemistry 2003, 42, 10462–10471. [Google Scholar] [CrossRef]
  9. Te, H.S.; Randall, G.; Jensen, D.M. Mechanism of Action of Ribavirin in the Treatment of Chronic Hepatitis C. Gastroenterol. Hepatol. 2007, 3, 218–225. [Google Scholar]
  10. Sheng, Z.; Liu, R.; Yu, J.; Ran, Z.; Newkirk, S.J.; An, W.; Li, F.; Wang, D. Identification and Characterization of Viral Defective RNA Genomes in Influenza B Virus. J. Gen. Virol. 2018, 99, 475–488. [Google Scholar] [CrossRef]
  11. Galli, A.; Mens, H.; Gottwein, J.M.; Gerstoft, J.; Bukh, J. Antiviral Effect of Ribavirin against HCV Associated with Increased Frequency of G-to-A and C-to-U Transitions in Infectious Cell Culture Model. Sci. Rep. 2018, 8, 4619. [Google Scholar] [CrossRef] [Green Version]
  12. Furuta, Y.; Takahashi, K.; Fukuda, Y.; Kuno, M.; Kamiyama, T.; Kozaki, K.; Nomura, N.; Egawa, H.; Minami, S.; Watanabe, Y.; et al. In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705. Antimicrob. Agents Chemother. 2002, 46, 977–981. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Sidwell, R.W.; Barnard, D.L.; Day, C.W.; Smee, D.F.; Bailey, K.W.; Wong, M.-H.; Morrey, J.D.; Furuta, Y. Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice. Antimicrob. Agents Chemother. 2007, 51, 845–851. [Google Scholar]
  14. Baranovich, T.; Wong, S.-S.; Armstrong, J.; Marjuki, H.; Webby, R.J.; Webster, R.G.; Govorkova, E.A. T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro. J. Virol. 2013, 87, 3741–3751. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Jin, Z.; Smith, L.K.; Rajwanshi, V.K.; Kim, B.; Deval, J. The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase. PLoS ONE 2013, 8, e68347. [Google Scholar] [CrossRef] [PubMed]
  16. Sabina, R.L.; Holmes, E.W.; Becker, M.A. The Enzymatic Synthesis of 5-Amino-4-Imidazolecarboxamide Riboside Triphosphate (ZTP). Science 1984, 223, 1193–1195. [Google Scholar] [CrossRef] [PubMed]
  17. Tarashima, N.S.; Kumanomido, Y.; Nakashima, K.; Tanaka, Y.; Minakawa, N. Synthesis of a Cyclic Dinucleotide Analogue with Ambiguous Bases, 5-Aminoimidazole-4-carboxamide. J. Org. Chem. 2021, 86, 15004–15010. [Google Scholar]
  18. Napoli, L.D.; Messere, A.; Montesarchio, D.; Piccialli, G. Synthesis of [1-15N]-Labeled 2′-Deoxyinosine and 2′-Deoxyadenosine. J. Org. Chem. 1995, 60, 2251–2253. [Google Scholar] [CrossRef]
  19. Oliviero, G.; Amato, J.; Borbone, N.; D’Errico, S.; Piccialli, G.; Mayol, L. Synthesis of N-1 and Ribose Modified Inosine Analogues on Solid Support. Tetrahedron Lett. 2007, 48, 397–400. [Google Scholar]
  20. Oliviero, G.; Amato, J.; Borbone, N.; D’Errico, S.; Piccialli, G.; Bucci, E.; Piccialli, V.; Mayol, L. Synthesis of 4-N-Alkyl and Ribose-Modified AICAR Analogues on Solid Support. Tetrahedron 2008, 64, 6475–6481. [Google Scholar] [CrossRef]
  21. Ouchi, H.; Asakawa, T.; Ikeuchi, K.; Inai, M.; Choi, J.-H.; Kawagishi, H.; Kan, T. Synthesis of Double-13C-Labeled Imidazole Derivatives. Tetrahedron Lett. 2018, 59, 3516–3518. [Google Scholar] [CrossRef]
  22. Narukulla, R.; Shuker, D.E.G.; Xu, Y.-Z. Post-Synthetic and Site-Specific Modification of Endocyclic Nitrogen Atoms of Purines in DNA and Its Potential for Biological and Structural Studies. Nucleic Acids Res. 2005, 33, 1767–1778. [Google Scholar] [CrossRef] [PubMed]
  23. Guckian, K.M.; Schweitzer, B.A.; Ren, R.X.-F.; Sheils, C.J.; Paris, P.L.; Tahmassebi, D.C.; Kool, E.T. Experimental Measurement of Aromatic Stacking Affinities in the Context of Duplex DNA. J. Am. Chem. Soc. 1996, 118, 8182–8183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Frisch, G.W.; Trucks, H.B.; Schlegel, G.E.; Scuseria, M.A.; Robb, J.R.; Cheeseman, G.; Scalmani, V.; Barone, B.; Mennucci, G.A.; Petersson, H.; et al. Gaussian 09; Revision E.01; Gaussian, Inc.: Wallingford, CT, USA, 2013. [Google Scholar]
  25. Sugimoto, N.; Nakano, S.; Yoneyama, M.; Honda, K. Improved Thermodynamic Parameters and Helix Initiation Factor to Predict Stability of DNA Duplexes. Nucleic Acids Res. 1996, 24, 4501–4505. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Structures of ambiguous nucleobases with a carboxamide group. (a) Z-base, (b) ribavirin, and (c) T-705. Rotatable carboxamide groups are highlighted in red.
Figure 1. Structures of ambiguous nucleobases with a carboxamide group. (a) Z-base, (b) ribavirin, and (c) T-705. Rotatable carboxamide groups are highlighted in red.
Molecules 28 03265 g001
Scheme 1. Preparation of the N1-dinitrophenyl-2′-deoxyinosine phosphoramidite derivative (4). DNP, 2,4-dinitrophenyl, highlighted in blue.
Scheme 1. Preparation of the N1-dinitrophenyl-2′-deoxyinosine phosphoramidite derivative (4). DNP, 2,4-dinitrophenyl, highlighted in blue.
Molecules 28 03265 sch001
Figure 2. Preparation of ODNs containing Z-base. (a) Schematic procedures for Z-base construction on a support-bonded ODN, and LC-MS analysis after treatment by (b) ethylenediamine at 50 °C, and (c) 1,3-propanediamine at 50 °C. Samples were analyzed by UPLC using a BEH C18 column (Waters, 2.1 × 50 mm, 1.7 μm) eluted with linear gradient from 5% to 40% MeOH with 3.5 mM triethylamine (TEA), 40 mM 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) (0.3 mL/min for 15 min). ABz, N6-benzoyladenine; Gibu, N2-isobutyrylguanine; CAc, N4-acetylcytosine.
Figure 2. Preparation of ODNs containing Z-base. (a) Schematic procedures for Z-base construction on a support-bonded ODN, and LC-MS analysis after treatment by (b) ethylenediamine at 50 °C, and (c) 1,3-propanediamine at 50 °C. Samples were analyzed by UPLC using a BEH C18 column (Waters, 2.1 × 50 mm, 1.7 μm) eluted with linear gradient from 5% to 40% MeOH with 3.5 mM triethylamine (TEA), 40 mM 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) (0.3 mL/min for 15 min). ABz, N6-benzoyladenine; Gibu, N2-isobutyrylguanine; CAc, N4-acetylcytosine.
Molecules 28 03265 g002
Figure 3. Thermal and thermodynamic parameters of DNA duplexes containing Z-base [a]. [a] All experiments were carried out in a buffer containing 100 mM NaCl, 10 mM Na2HPO4, and 1 mM Na2EDTA (pH 7.0). Thermodynamic parameters were derived from the average values obtained from curve fitting and Tm–1 versus ln(Ct/4) plots. Tm was calculated at a strand concentration of 10 μM. [b] ∆Tm and ∆∆G° values were calculated based on the values determined for a natural A:T pair (entry 5). [c] ∆Tm and ∆∆G° values were calculated based on the values determined for a natural A:T pair (entry 14). * p < 0.05 and ** p < 0.005 by Student’s t-test. Z-bases are highlighted in red.
Figure 3. Thermal and thermodynamic parameters of DNA duplexes containing Z-base [a]. [a] All experiments were carried out in a buffer containing 100 mM NaCl, 10 mM Na2HPO4, and 1 mM Na2EDTA (pH 7.0). Thermodynamic parameters were derived from the average values obtained from curve fitting and Tm–1 versus ln(Ct/4) plots. Tm was calculated at a strand concentration of 10 μM. [b] ∆Tm and ∆∆G° values were calculated based on the values determined for a natural A:T pair (entry 5). [c] ∆Tm and ∆∆G° values were calculated based on the values determined for a natural A:T pair (entry 14). * p < 0.05 and ** p < 0.005 by Student’s t-test. Z-bases are highlighted in red.
Molecules 28 03265 g003
Figure 4. Stacking affinity of Z-base [a]. [a] All experiments were carried out in a buffer containing 1 M NaCl, 10 mM Na2HPO4, and 1 mM Na2EDTA (pH 7.0). Thermodynamic parameters were derived from the average values obtained from curve fitting and Tm–1versus ln(Ct/4) plots. Tm was calculated at a strand concentration of 10 μM. [b] ∆Tm and ∆∆G° values were calculated based on the values of entry 1. * p < 0.05 by Student’s t-test.
Figure 4. Stacking affinity of Z-base [a]. [a] All experiments were carried out in a buffer containing 1 M NaCl, 10 mM Na2HPO4, and 1 mM Na2EDTA (pH 7.0). Thermodynamic parameters were derived from the average values obtained from curve fitting and Tm–1versus ln(Ct/4) plots. Tm was calculated at a strand concentration of 10 μM. [b] ∆Tm and ∆∆G° values were calculated based on the values of entry 1. * p < 0.05 by Student’s t-test.
Molecules 28 03265 g004
Figure 5. Behavior of the Z-base during replication catalyzed by DNA polymerase. (a) Sequence of the primer–template duplex used for single-nucleotide insertion. (b) Denaturing gel image of the products of single-nucleotide insertion by Klenow fragment DNA polymerase with incorporation of dNTP against A or Z in the template (lanes 2–9, 5 μM dNTP; lanes 11–18, 10 μM dNTP). (c) Steady-state kinetic parameters for the insertion of single nucleotide into a template–primer duplex. Assays were carried out at 37 °C for 2 min with 0.2–0.8 μM template–primer duplex, 0.025 units μL–1 of KF exo, and 0.05–5 μM TTP in a solution (10 μL) containing 10 mM Tris-HCl (pH 7.9) buffer, 50 mM NaCl, 10 mM MgCl2, and 1 mM dithiothreitol (DTT). Each parameter was averaged from three data sets. (d) Sequences of template and primers for PCR. (e) Agarose gel analysis of products after PCR with Taq DNA polymerase. The reaction mixture contained 0.5 pM template, 1×ThermoPol® Buffer (New England Biolabs), 0.5 μM primers, 0.2 mM dNTPs, and 0.025 units μL−1 of Taq DNA polymerase in a volume of 50 μL. (f) Sequencing of products amplified from a DNA template containing a Z-base. The sequences of each amplicon (1.125 μg) were analyzed with 4 pmol of primer for both sense and antisense strands by an ABI PRISM 3100 Genetic Analyzer. Z-bases are highlighted in red.
Figure 5. Behavior of the Z-base during replication catalyzed by DNA polymerase. (a) Sequence of the primer–template duplex used for single-nucleotide insertion. (b) Denaturing gel image of the products of single-nucleotide insertion by Klenow fragment DNA polymerase with incorporation of dNTP against A or Z in the template (lanes 2–9, 5 μM dNTP; lanes 11–18, 10 μM dNTP). (c) Steady-state kinetic parameters for the insertion of single nucleotide into a template–primer duplex. Assays were carried out at 37 °C for 2 min with 0.2–0.8 μM template–primer duplex, 0.025 units μL–1 of KF exo, and 0.05–5 μM TTP in a solution (10 μL) containing 10 mM Tris-HCl (pH 7.9) buffer, 50 mM NaCl, 10 mM MgCl2, and 1 mM dithiothreitol (DTT). Each parameter was averaged from three data sets. (d) Sequences of template and primers for PCR. (e) Agarose gel analysis of products after PCR with Taq DNA polymerase. The reaction mixture contained 0.5 pM template, 1×ThermoPol® Buffer (New England Biolabs), 0.5 μM primers, 0.2 mM dNTPs, and 0.025 units μL−1 of Taq DNA polymerase in a volume of 50 μL. (f) Sequencing of products amplified from a DNA template containing a Z-base. The sequences of each amplicon (1.125 μg) were analyzed with 4 pmol of primer for both sense and antisense strands by an ABI PRISM 3100 Genetic Analyzer. Z-bases are highlighted in red.
Molecules 28 03265 g005
Figure 6. Possible configurations of nucleoside analogs with a rotatable carboxamide group on the nucleobases. Rotatable carboxamide groups are highlighted in red. Blue hashed lines indicate hydrogen bonding interactions.
Figure 6. Possible configurations of nucleoside analogs with a rotatable carboxamide group on the nucleobases. Rotatable carboxamide groups are highlighted in red. Blue hashed lines indicate hydrogen bonding interactions.
Molecules 28 03265 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nogi, Y.; Saito-Tarashima, N.; Karanjit, S.; Minakawa, N. Synthesis and Behavior of DNA Oligomers Containing the Ambiguous Z-Nucleobase 5-Aminoimidazole-4-carboxamide. Molecules 2023, 28, 3265. https://doi.org/10.3390/molecules28073265

AMA Style

Nogi Y, Saito-Tarashima N, Karanjit S, Minakawa N. Synthesis and Behavior of DNA Oligomers Containing the Ambiguous Z-Nucleobase 5-Aminoimidazole-4-carboxamide. Molecules. 2023; 28(7):3265. https://doi.org/10.3390/molecules28073265

Chicago/Turabian Style

Nogi, Yuhei, Noriko Saito-Tarashima, Sangita Karanjit, and Noriaki Minakawa. 2023. "Synthesis and Behavior of DNA Oligomers Containing the Ambiguous Z-Nucleobase 5-Aminoimidazole-4-carboxamide" Molecules 28, no. 7: 3265. https://doi.org/10.3390/molecules28073265

APA Style

Nogi, Y., Saito-Tarashima, N., Karanjit, S., & Minakawa, N. (2023). Synthesis and Behavior of DNA Oligomers Containing the Ambiguous Z-Nucleobase 5-Aminoimidazole-4-carboxamide. Molecules, 28(7), 3265. https://doi.org/10.3390/molecules28073265

Article Metrics

Back to TopTop